Nuwellis (NUWE) Return on Capital Employed Growth (3y) (2015 - 2026)
Nuwellis (NUWE) Return on Capital Employed Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -236.00 |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 281.00 |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 145.00 |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 446.00 |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | -433.00 |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 1,627.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -62.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | - |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 370.00 |
| 10 | Nuwellis | 204,206.50 | -3.72 Mn | 1.50 Mn | -17,258.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17,258.00 |
| Mar 31, 2026 | -34,247.00 |
| Dec 31, 2025 | -17,454.00 |
| Sep 30, 2025 | -11,577.00 |
| Jun 30, 2025 | -14,588.00 |
| Mar 31, 2025 | -8,825.00 |
| Dec 31, 2024 | -12,408.00 |
| Sep 30, 2024 | -25,513.00 |
| Jun 30, 2024 | -50,779.00 |
| Mar 31, 2024 | -34,972.00 |
| Dec 31, 2023 | -14,416.00 |
| Sep 30, 2023 | -6,383.00 |
| Jun 30, 2023 | 6,462.00 |
| Mar 31, 2023 | 20,873.00 |
| Dec 31, 2022 | 45,668.00 |
| Sep 30, 2022 | 17,051.00 |
| Jun 30, 2022 | 7,525.00 |
| Mar 31, 2022 | 10,533.00 |
| Dec 31, 2021 | 16,142.00 |
| Sep 30, 2021 | 14,365.00 |